Open Pharma – Innovations in medical publishing

peter.suber's bookmarks 2017-06-30

Summary:

"Although scientific publishing is changing fast, most pharma-sponsored research continues to be published through a traditional route of peer-reviewed journals. The current route is slow, with limited transparency and restricted access to research outputs. This has a negative impact on biomedical research and, ultimately, patient healthcare.

Many groups are discussing the future of scientific publishing but, so far, the pharmaceutical industry has provided limited input into the discussions. With half of all biomedical research funding coming from industry, and with substantial issues of trust and transparency still to be addressed, our group thinks not only that industry should be involved in the discussions but also that it should help to drive change. Non-pharmaceutical-industry funders such as the Wellcome Trust and the Bill & Melinda Gates Foundation have been the main drivers of innovation so far. It’s time for the pharmaceutical industry to join them...."

Link:

https://openpharma.blog/

From feeds:

Open Access Tracking Project (OATP) » peter.suber's bookmarks

Tags:

oa.pharma oa.industry oa.medicine oa.advocacy

Date tagged:

06/30/2017, 12:38

Date published:

06/30/2017, 08:38